Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Rev Med Interne ; 41(3): 200-205, 2020 Mar.
Artículo en Francés | MEDLINE | ID: mdl-31980187

RESUMEN

INTRODUCTION: Chronic enterovirus infections can occur in primary immunodeficiency with hypogammaglobulinemia. They usually associate meningitis and myofasciitis. Such infections have also been described in adults with rituximab-induced hypogammaglobulinemia. CASE REPORT: We report the case of a 33-year-old woman who was given rituximab for immune thrombocytopenia and developed rituximab-induced hypogammaglobulinemia (IgG 4.4g/L). One year after the last rituximab infusion, she developed lower limbs myofasciitis, followed two months later by a chronic lymphocytic meningitis. PCR in the serum and the cerebrospinal fluid at the time of the meningitis and the myofasciitis were positive to the same enterovirus (echovirus 11) while it was negative in the fascia biopsy. Under treatment with intravenous immunoglobulins, all symptoms and laboratory abnormalities improved and enterovirus PCR became negative. CONCLUSION: We report a case of chronic enterovirus infection associating meningitis and myofasciitis in an adult with rituximab-induced hypogammaglobulinemia. Outcome was favorable under treatment with intravenous immunoglobulins.


Asunto(s)
Agammaglobulinemia/inducido químicamente , Infecciones por Enterovirus/inducido químicamente , Rituximab/efectos adversos , Adulto , Agammaglobulinemia/virología , Enfermedad Crónica , Infecciones por Enterovirus/inmunología , Infecciones por Enterovirus/terapia , Fascitis/inducido químicamente , Fascitis/terapia , Femenino , Francia , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Meningitis/inducido químicamente , Meningitis/complicaciones , Meningitis/terapia , Miositis/inducido químicamente , Miositis/complicaciones , Miositis/terapia , Púrpura Trombocitopénica Idiopática/tratamiento farmacológico
2.
J Pediatr Hematol Oncol ; 41(1): e27-e29, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-29315142

RESUMEN

A boy with central nervous system relapse of Burkitt leukemia developed fever and neurologic symptoms and cognitive impairment. He had received multi-drug chemotherapy including rituximab. Enterovirus (EV) was detected in cerebrospinal fluid by polymerase chain reaction, and magnetic resonance imaging findings were consistent with viral infection. The patient was treated with intravenous immunoglobulin and within 1 month cleared his EV. Rituximab can cause a profound B-cell deficiency predisposing patients to infections including EV encephalitis. This is the first report of enteroviral encephalitis in a child undergoing treatment for lymphoma with rituximab and suggests the need to watch for this complication of therapy.


Asunto(s)
Linfoma de Burkitt , Neoplasias del Sistema Nervioso Central , Encefalitis Viral , Infecciones por Enterovirus , Enterovirus/genética , Rituximab/efectos adversos , Linfoma de Burkitt/líquido cefalorraquídeo , Linfoma de Burkitt/tratamiento farmacológico , Linfoma de Burkitt/genética , Linfoma de Burkitt/virología , Neoplasias del Sistema Nervioso Central/líquido cefalorraquídeo , Neoplasias del Sistema Nervioso Central/tratamiento farmacológico , Neoplasias del Sistema Nervioso Central/genética , Neoplasias del Sistema Nervioso Central/virología , Preescolar , Encefalitis Viral/líquido cefalorraquídeo , Encefalitis Viral/inducido químicamente , Encefalitis Viral/genética , Infecciones por Enterovirus/líquido cefalorraquídeo , Infecciones por Enterovirus/inducido químicamente , Infecciones por Enterovirus/genética , Humanos , Masculino , Rituximab/administración & dosificación
3.
Curr Environ Health Rep ; 5(4): 464-485, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30280317

RESUMEN

PURPOSE OF REVIEW: Selenium, a trace element, is ubiquitous in the environment. The main source of human exposure is diet. Despite its nutritional benefits, it is one of the most toxic naturally occurring elements. Selenium deficiency and overexposure have been associated with adverse health effects. Its level of toxicity may depend on its chemical form, as inorganic and organic species have distinct biological properties. RECENT FINDINGS: Nonexperimental and experimental studies have generated insufficient evidence for a role of selenium deficiency in human disease, with the exception of Keshan disease, a cardiomyopathy. Conversely, recent randomized trials have indicated that selenium overexposure is positively associated with type 2 diabetes and high-grade prostate cancer. In addition, a natural experiment has suggested an association between overexposure to inorganic hexavalent selenium and two neurodegenerative diseases, amyotrophic lateral sclerosis and Parkinson's disease. Risk assessments should be revised to incorporate the results of studies demonstrating toxic effects of selenium. Additional observational studies and secondary analyses of completed randomized trials are needed to address the uncertainties regarding the health risks of selenium exposure.


Asunto(s)
Enfermedades Cardiovasculares/inducido químicamente , Enfermedades del Sistema Endocrino/inducido químicamente , Exposición a Riesgos Ambientales/efectos adversos , Enfermedades del Sistema Nervioso/inducido químicamente , Selenio/efectos adversos , Oligoelementos/efectos adversos , Esclerosis Amiotrófica Lateral/inducido químicamente , Cardiomiopatías/inducido químicamente , Enfermedad Crónica/epidemiología , Diabetes Mellitus Tipo 2/inducido químicamente , Infecciones por Enterovirus/inducido químicamente , Humanos , Masculino , Neoplasias/inducido químicamente , Enfermedad de Parkinson/etiología , Medición de Riesgo
5.
Neth J Med ; 68(5): 221-3, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20508271

RESUMEN

A 64-year-old woman with a progressive marginal zone lymphoma for which she had received induction therapy with six courses of rituximab and fludarabine presented with fever while receiving maintenance therapy with rituximab. In addition to the fever she complained of nausea, vomiting, weight loss and fatigue. After an extensive diagnostic procedure no cause was found for the fever. Finally, additional testing showed a positive polymerase chain reaction (PCR) for enterovirus in the cerebrospinal fluid and faeces. Because the immunoglobulin G level of our patient was 4.06 g/l (normal values 5.2 to 16 g/l), she was treated with intravenous immunoglobulins (IVI g) weekly with the goal to maintain an IgG level above 10 g/l. This resulted in a significant rise in anti-enteroviral antibodies from 10 IE /ml to 106 IE /ml. One month after treatment with IVI g, while withholding the rituximab, the PCR for enterovirus on faeces was negative and antibodies to the enterovirus in the serum had returned to normal levels. Rituximab can cause a prolonged B-cell deficiency resulting in hypogammaglobulinaemia. We believe that treatment with ritxumab may have played a significant role in the development of this rare central nervous system infection.


Asunto(s)
Anticuerpos Monoclonales/efectos adversos , Encefalitis Viral/virología , Infecciones por Enterovirus/etiología , Inmunoglobulinas/administración & dosificación , Linfoma de Células B de la Zona Marginal/tratamiento farmacológico , Agammaglobulinemia/inducido químicamente , Agammaglobulinemia/tratamiento farmacológico , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales de Origen Murino , Antineoplásicos/efectos adversos , Antineoplásicos/uso terapéutico , Encefalitis Viral/inducido químicamente , Encefalitis Viral/etiología , Encefalitis Viral/inmunología , Infecciones por Enterovirus/inducido químicamente , Infecciones por Enterovirus/inmunología , Femenino , Humanos , Persona de Mediana Edad , Rituximab
7.
Pediatr Infect Dis J ; 29(6): 524-9, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20104199

RESUMEN

BACKGROUND: Human enterovirus 71 (HEV71) causes outbreaks of life-threatening diseases throughout the world. The genesis of these severe diseases is unknown. METHODS: During an outbreak of HEV71 infection, we investigated risk factors for critical illness. We developed a modified pediatric index of mortality (mPIM) incorporating heart rate, temperature, white blood cell count, respiratory rate, chest infiltrates, skin color, reflexes, responsiveness, and mobility. We calculated the mPIM for 103 patients (22 deaths) using complete scoring criteria in the medical record. In a case-control study, we compared cases (mPIM > or =10 or death) with controls (mPIM = 0-9) by drugs received within 96 hours after onset of fever, initial temperature, age, and nutritional anthropometry. RESULTS: About 66% (68/103) of the patients with an mPIM score (28 cases and 40 controls) had data on initial exposures. About 50% of the 28 cases and 18% of the 40 controls received an injection to treat fever during the first 96 hours after onset (Odds ratio [OR] = 7.0, 95% confidence interval [CI]: 1.8-28). Injections containing exclusively glucocorticoids (OR = 4.8, 95% CI: 1.2-21) or pyrazolones (OR = 4.1, 95% CI: 0.91-19, P = 0.047) were risk factors for severe HEV71 infection. About 25% of cases and 5% of controls received both drugs parenterally while 7% of cases and 30% of controls received neither (OR = 21, 95% CI: 1.8-305). Conversely, cases and controls had identical average initial temperature, and did not differ significantly by age, sex, nutritional measurements, use of other drugs, or timeliness of medical care received. CONCLUSION: Fever treatment with glucocorticoids and/or pyrazolones is a risk factor for life-threatening HEV71 infection.


Asunto(s)
Enterovirus Humano A/aislamiento & purificación , Infecciones por Enterovirus/inducido químicamente , Fiebre/tratamiento farmacológico , Glucocorticoides/efectos adversos , Pirazolonas/efectos adversos , Enfermedad Aguda , Niño , Preescolar , China , Brotes de Enfermedades , Infecciones por Enterovirus/virología , Femenino , Glucocorticoides/uso terapéutico , Humanos , Lactante , Masculino , Pirazolonas/uso terapéutico , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Riesgo , Índice de Severidad de la Enfermedad , Estadísticas no Paramétricas
10.
J Clin Lab Anal ; 22(3): 216-9, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18484653

RESUMEN

For a better understanding of the role of the viral load, free radicals, and cytokines in viral meningitis, we surveyed cerebrospinal fluid (CSF) obtained from patients below 1 year of age who showed positive for enterovirus. In their first examinations interleukin (IL)-6 and free radicals increased whereas pleocytosis was rarely observed. IL-6 decreased within the short period. Viral loads and free radicals increased simultaneously. IL-6 and free radicals of CSF are helpful for diagnosis and treatment of viral meningitis at an early stage.


Asunto(s)
Infecciones por Enterovirus/líquido cefalorraquídeo , Meningitis Viral/líquido cefalorraquídeo , Carga Viral , Enterovirus/fisiología , Infecciones por Enterovirus/inducido químicamente , Infecciones por Enterovirus/virología , Femenino , Radicales Libres/líquido cefalorraquídeo , Humanos , Inmunoglobulinas Intravenosas/administración & dosificación , Lactante , Recién Nacido , Interleucina-6/líquido cefalorraquídeo , Masculino , Meningitis Viral/diagnóstico , Meningitis Viral/virología , ARN Viral/líquido cefalorraquídeo , Resultado del Tratamiento
11.
Pediatr Cardiol ; 27(5): 577-84, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16933070

RESUMEN

The mechanism of heart failure in patients with enterovirus 71 rhombencephalitis (brain stem encephalitis) remains unknown. Our previous reports hypothesized that a catecholamine storm induced by rhombencephalitis may account for the heart failure. The aim of this study was to develop a novel feline model of norepinephrine cardiotoxicity and compare the resulting heart failure to that in children with enterovirus 71 rhombencephalitis. Nine of 75 children (12%) with enterovirus 71 rhombencephalitis (5 boys and 4 girls; age, 4-28 months; median age, 16 months) were complicated with left ventricular hypokinesia (ejection fraction, 31 +/- 9%). Six cats (weight, 3.03 +/- 0.64 kg) were administered intravenous norepinephrine 30 microg/kg/min for 3 hours. Echocardiography assessed the left ventricular diameter and function before and after the administration of norepinephrine. Pathology studies included hematoxylin and eosin stain and in situ terminal deoxyribonucleotidyl transferase-mediated dUTP nick end-labeling assay. In the feline model, norepinephrine induced significant left ventricular dilatation (end diastolic diameter from 1.18 +/- 0.19 to 1.62 +/- 0.22 cm, p = 0.001; endsystolic diameter from 0.54 +/- 0.09 to 1.36 +/- 0.32 cm, p = < 0.001) and hypokinesia (ejection fraction from 87.5 +/- 4.1 to 35.2 +/- 16.3%, p = 0.001). Heart specimens from 4 patients and six cats showed similar pathology findings, including myocardial hemorrhage, cardiomyocyte apoptosis, and coagulative myocytolysis, which is characterized by sarcoplasmic coagulation, granulation, vacuolization, myofibrillar waving, and disruption. Both groups showed no significant inflammatory reaction. In conclusion, heart failure in patients with enterovirus 71 rhombencephalitis is similar to that in cats with norepinephrine cardiotoxicity. Norepinephrine cardiotoxicity may play a role in the pathogenesis of heart failure in enterovirus 71 rhombencephalitis.


Asunto(s)
Encefalitis Viral/complicaciones , Infecciones por Enterovirus/inducido químicamente , Enterovirus/clasificación , Insuficiencia Cardíaca/etiología , Norepinefrina/toxicidad , Rombencéfalo/virología , Animales , Apoptosis , Gatos , Preescolar , Ecocardiografía , Encefalitis Viral/virología , Enterovirus/aislamiento & purificación , Infecciones por Enterovirus/virología , Femenino , Insuficiencia Cardíaca/diagnóstico , Insuficiencia Cardíaca/fisiopatología , Ventrículos Cardíacos/diagnóstico por imagen , Ventrículos Cardíacos/efectos de los fármacos , Ventrículos Cardíacos/patología , Humanos , Lactante , Masculino , Índice de Severidad de la Enfermedad , Función Ventricular Izquierda/efectos de los fármacos
12.
Pathol Res Pract ; 198(10): 689-96, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12498225

RESUMEN

Immunohistochemical and molecular-pathologic techniques have improved the diagnosis of myocarditis as compared with conventional histologic staining methods done according to the Dallas criteria. Most investigations were carried out on adults, and only a few authors investigating childhood deaths applied these modern methods, used for diagnosing myocarditis. We report on four children under one year of age, who suddenly died without prodromal symptoms. Their deaths were attributed to SIDS (sudden infant death syndrome). Immunohistochemical (LCA, CD68, CD45R0, MHC-class-II-molecules, VP1-capsid-protein of enteroviruses) and molecular-pathologic (RT-PCR) investigations, however, suggested that death was caused by a coxsackie-B3-myocarditis. In the future, these methods should be used for investigating cases with suspicion of SIDS.


Asunto(s)
Enterovirus Humano B/aislamiento & purificación , Infecciones por Enterovirus/inducido químicamente , Miocarditis/diagnóstico , Muerte Súbita del Lactante/diagnóstico , Biomarcadores/análisis , ADN Viral/análisis , Diagnóstico Diferencial , Enterovirus Humano B/genética , Infecciones por Enterovirus/complicaciones , Femenino , Técnica del Anticuerpo Fluorescente Indirecta , Humanos , Técnicas para Inmunoenzimas , Inmunohistoquímica , Lactante , Masculino , Miocarditis/virología , Miocardio/química , Miocardio/patología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Muerte Súbita del Lactante/etiología
13.
Pediatr Hematol Oncol ; 19(3): 205-10, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-11936734

RESUMEN

Enteroviruses are common causes of viral encephalitis in childhood and the most common cause of myocarditis. The prognosis is good with exception of the immunocompromised children who are at higher risk with increased mortality. A case of a 7-year-old boy with acute lymphoblastic leukemia and coxsackievirus B5-associated encephalitis and myocarditis is described. The boy was in complete remission and coxsackievirus B5 infection occurred 22 months after the beginning of chemotherapy. The clinical manifestations were fever, seizures, and altered consciousness. He underwent only supportive treatment. He had an excellent outcome; 2 years later he is still in complete remission with normal electroencephalogram and normal cardiac function.


Asunto(s)
Encefalitis Viral/inducido químicamente , Miocarditis/inducido químicamente , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicaciones , Antineoplásicos/efectos adversos , Niño , Encefalitis Viral/diagnóstico , Enterovirus Humano B , Infecciones por Enterovirus/inducido químicamente , Infecciones por Enterovirus/complicaciones , Humanos , Huésped Inmunocomprometido , Masculino , Miocarditis/diagnóstico , Miocarditis/virología , Infecciones Oportunistas/inducido químicamente , Infecciones Oportunistas/diagnóstico , Infecciones Oportunistas/virología , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/virología , Inducción de Remisión , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA